Paul Molloy has over 25 years of experience in a range of public, private and venture capital funded healthcare companies.
Prior to becoming the chief executive of Applaud Medical in October 2022, Mr Molloy was the president and chief executive of US-based medical device company Clearflow, and chief executive of Silicon Valley-based venture funded vascular navigation company VasoNova which was later acquired by Teleflex. Following the acquisition, he became president of Teleflex' division ARROW Vascular.
Mr Molloy had also exited a number of US medical devices firms including publicly traded cerebral oxygenation monitoring firm CAS Medical and Revolutionary Medical Devices, which develops products for airway management, improving patient outcomes from sedation and anaesthesia. He has also been on the board of Augustine Medical, a privately-held market leader in medical arena temperature management, and a venture capital-funded critical care firm Inscope.
